Publications 2022

Anda EE, Braaten T, Borch KB, Nøst TH, Chen SLF, Lukic M, Lund E, Forland F, Leon DA, Winje BA, Kran AB, Kalager M, Johansen FL, Sandanger TM (2022)
Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21
Euro Surveill, 27 (13)
DOI 10.2807/1560-7917.ES.2022.27.13.2100376, PubMed 35362405

Havdal LB, Bøås H, Bekkevold T, Bakken Kran AM, Rojahn AE, Størdal K, Debes S, Døllner H, Nordbø SA, Barstad B, Haarr E, Fernández LV, Nakstad B, Inchley C, Flem E (2022)
Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age
Front Pediatr, 10, 1004739
DOI 10.3389/fped.2022.1004739, PubMed 36110112

Nissen-Meyer LSH, Hervig T, Fevang B, Norheim G, Kran AB, Vaage JT, Flesland Ø (2022)
COVID-19 convalescent plasma from Norwegian blood donors
Tidsskr Nor Laegeforen, 142 (9)
DOI 10.4045/tidsskr.22.0057, PubMed 35699539

Tunheim G, Rø GØI, Chopra A, Aase A, Kran AB, Vaage JT, Lund-Johansen F, Hungnes O (2022)
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021
Influenza Other Respir Viruses (in press)
DOI 10.1111/irv.13024, PubMed 35770841

Wæhre T, Tunheim G, Bodin JE, Laake I, Kvale D, Kran AB, Brekke H, Løken R, Oftung F, Mjaaland S, Dyrhol-Riise AM (2022)
Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014-2018
Infect Dis (Lond), 54 (5), 367-377
DOI 10.1080/23744235.2021.2022196, PubMed 34983302

Publications 2021

Bruun T, Salamanca BV, Bekkevold T, Døllner H, Gibory M, Gilje AM, Haarr E, Kran AB, Leegaard TM, Nakstad B, Nordbø SA, Rojahn A, Størdal K, Flem E, Norwegian Enhanced Pediatric Immunisation Surveillance Network (2021)
Impact of the Rotavirus Vaccination Program in Norway After Four Years With High Coverage
Pediatr Infect Dis J, 40 (4), 368-374
DOI 10.1097/INF.0000000000003020, PubMed 33399430

Havdal LB, Bøås H, Bekkevold T, Kran AB, Rojahn AE, Størdal K, Debes S, Døllner H, Nordbø SA, Barstad B, Haarr E, Fernández LV, Nakstad B, Inchley C, Flem E (2021)
The burden of respiratory syncytial virus in children under 5 years of age in Norway
J Infect, 84 (2), 205-215
DOI 10.1016/j.jinf.2021.12.008, PubMed 34906596

Landaas ET, Storm ML, Tollånes MC, Barlinn R, Kran AB, Bragstad K, Christensen A, Andreassen T (2021)
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort
J Clin Virol, 137, 104789
DOI 10.1016/j.jcv.2021.104789, PubMed 33736946

Tunheim G, Rø GØI, Tran T, Kran AB, Andersen JT, Vaage EB, Kolderup A, Vaage JT, Lund-Johansen F, Hungnes O (2021)
Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic
Influenza Other Respir Viruses, 16 (2), 204-212
DOI 10.1111/irv.12932, PubMed 34751488

Publications 2020

Orlien SMS, Ahmed TA, Ismael NY, Berhe Belay N, Kran AB, Gundersen SG, Johannessen A (2020)
Field performance of HBsAg rapid diagnostic tests in rural Ethiopia
J Virol Methods, 289, 114061
DOI 10.1016/j.jviromet.2020.114061, PubMed 33388369

Tollånes MC, Bakken Kran AM, Abildsnes E, Jenum PA, Breivik AC, Sandberg S (2020)
Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
Clin Chem Lab Med, 58 (9), 1595-1600
DOI 10.1515/cclm-2020-0628, PubMed 32598303

Publications 2019

Paraskevis D, Beloukas A, Stasinos K, Pantazis N, de Mendoza C, Bannert N, Meyer L, Zangerle R, Gill J, Prins M, d'Arminio Montforte A, Kran AB, Porter K, Touloumi G, CASCADE collaboration of EuroCoord (2019)
HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
BMC Med, 17 (1), 4
DOI 10.1186/s12916-018-1241-1, PubMed 30616632

Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
BMC Infect Dis, 19 (1), 80
DOI 10.1186/s12879-018-3570-2, PubMed 30669985

Quist-Paulsen E, Ormaasen V, Kran AB, Dunlop O, Ueland PM, Ueland T, Eikeland R, Aukrust P, Nordenmark TH (2019)
Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning
Sci Rep, 9 (1), 16158
DOI 10.1038/s41598-019-52570-2, PubMed 31695095

Publications 2018

Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K, for CASCADE Collaboration in EuroCoord (2018)
Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
AIDS, 32 (2), 161-169
DOI 10.1097/QAD.0000000000001689, PubMed 29112061

Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
J Neuroinflammation, 15 (1), 327
DOI 10.1186/s12974-018-1366-3, PubMed 30470234

Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
Stratification by interferon-γ release assay level predicts risk of incident TB
Thorax, 73 (7), 652-661
DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2016

Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, Jørgensen KK, Osnes LT, Bratlie J, Eide TJ, Dahl CP, Holter E, Tronstad RR, Hanevik K, Brattbakk HR, Kaveh F, Fiskerstrand T, Kran AB, Ueland T, Karlsen TH, Aukrust P, Lundin KE, Fevang B (2016)
A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
Am J Gastroenterol, 111 (10), 1467-1475
DOI 10.1038/ajg.2016.329, PubMed 27527747

Rosenstierne MW, Karlberg H, Bragstad K, Lindegren G, Stoltz ML, Salata C, Kran AM, Dudman SG, Mirazimi A, Fomsgaard A (2016)
Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests
J Clin Microbiol, 54 (10), 2521-9
DOI 10.1128/JCM.00346-16, PubMed 27466385

Publications 2015

Casadellà M, van Ham PM, Noguera-Julian M, van Kessel A, Pou C, Hofstra LM, Santos JR, Garcia F, Struck D, Alexiev I, Bakken Kran AM, Hoepelman AI, Kostrikis LG, Somogyi S, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Staneková D, Stanojevic M, Van Laethem K, Zidovec Lepej S et al. (2015)
Primary resistance to integrase strand-transfer inhibitors in Europe
J Antimicrob Chemother, 70 (10), 2885-8
DOI 10.1093/jac/dkv202, PubMed 26188038

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
Clin Infect Dis, 62 (5), 655-663
DOI 10.1093/cid/civ963, PubMed 26620652

Pfeiffer HC, Bragstad K, Skram MK, Dahl H, Knudsen PK, Chawla MS, Holberg-Petersen M, Vainio K, Dudman SG, Kran AM, Rojahn AE (2015)
Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014
Euro Surveill, 20 (10), 21062
DOI 10.2807/1560-7917.es2015.20.10.21062, PubMed 25788251

Publications 2014

Bragstad K, Jakobsen K, Rojahn AE, Skram MK, Vainio K, Holberg-Petersen M, Hungnes O, Dudman SG, Kran AM (2014)
High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
Influenza Other Respir Viruses, 9 (2), 59-63
DOI 10.1111/irv.12300, PubMed 25534826

Kran AM (2014)
[Local food at exotic vacation]
Tidsskr Nor Laegeforen, 134 (2), 192-3
DOI 10.4045/tidsskr.13.1372, PubMed 24477156

Kran AMB, Lind A, Sommerfelt MM, Baksaas I, Sørensen B, Kvale D (2014)
Comparable Cellular Immune Responses in Patients with and without Antiretroviral Treatment after Immunization with HIV-1 P24, P17 and Tat Consensus Peptides (Vacc-5q)
J AIDS Clin Res, 5 (4), 1000294
DOI 10.4172/2155-6113.1000296, PublikaID 217

Publications 2013

Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K, for CASCADE Collaboration in EuroCoord (2013)
Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration
PLoS One, 8 (7), e71174
DOI 10.1371/journal.pone.0071174, PubMed 23936260

Publications 2012

Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
Infectious encephalitis: a description of a Norwegian cohort
Scand J Infect Dis, 45 (3), 179-85
DOI 10.3109/00365548.2012.719634, PubMed 23113672

Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K, CASCADE collaboration in EuroCoord (2012)
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts
Clin Infect Dis, 56 (6), 888-97
DOI 10.1093/cid/cis1000, PubMed 23223594

Publications 2011

Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
BMC Infect Dis, 11, 75
DOI 10.1186/1471-2334-11-75, PubMed 21435254

Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2011)
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
APMIS, 120 (3), 204-9
DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677

Publications 2010

Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
AIDS, 24 (17), 2609-18
DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558

Publications 2009

Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
DOI 10.1128/JCM.00519-09, PubMed 19420166

Publications 2006

Kran AM, Kvale D (2006)
[Immunopathogenesis and therapeutic immunization in HIV-infection]
Tidsskr Nor Laegeforen, 126 (23), 3112-6
PubMed 17160117

Kran AM, Sørensen B, Sommerfelt MA, Nyhus J, Baksaas I, Kvale D (2006)
Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
AIDS, 20 (4), 627-30
DOI 10.1097/01.aids.0000210620.75707.ac, PubMed 16470131

Kran AMB (2006)
Peptide-based therapeutic immunizations targeting dendritic cells in chronic HIV-1 infection
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 402, 1 b. (flere pag.)
BIBSYS 060843748, ISBN 82-8080-169-3

Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
AIDS, 20 (6), 813-20
DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964

Publications 2005

Kran AM, Sommerfelt MA, Sørensen B, Nyhus J, Baksaas I, Bruun JN, Kvale D (2005)
Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
Vaccine, 23 (31), 4011-5
DOI 10.1016/j.vaccine.2005.03.010, PubMed 15963359

Kvale D, Kran AM, Sommerfelt MA, Nyhus J, Baksaas I, Bruun JN, Sørensen B (2005)
Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
AIDS, 19 (6), 563-7
DOI 10.1097/01.aids.0000163932.76531.c6, PubMed 15802974

Nyhus J, Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2005)
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
Vaccine, 24 (10), 1543-50
DOI 10.1016/j.vaccine.2005.10.012, PubMed 16289707

Publications 2004

Kran AM, Sørensen B, Nyhus J, Sommerfelt MA, Baksaas I, Bruun JN, Kvale D (2004)
HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
AIDS, 18 (14), 1875-83
DOI 10.1097/00002030-200409240-00003, PubMed 15353973